Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molson Coors Brewing Company

Investor Deadline Approaching: Faruqi & Faruqi LLP Investigates Claims on Behalf of Investors of Conatus Pharmaceuticals, Inc.

New York, NY – Faruqi & Faruqi LLP, a leading national securities law firm, is investigating claims against Conatus Pharmaceuticals, Inc. ("Conatus" or the "Company") (NASDAQ: CNAT) on behalf of investors who have suffered losses.

On March 10, 2023, Conatus announced that it would be suspending its clinical development program for its lead product candidate, Lenabasum, due to the Company's inability to secure additional funding. This news caused the Company's stock price to plummet, resulting in significant losses for investors.

Faruqi & Faruqi LLP is a nationally recognized law firm with a strong track record of success in securities cases. The firm is interested in speaking with investors who have significant losses and would like to discuss the possibility of recovering those losses.

Investors who would like to discuss their potential claims can contact Faruqi & Faruqi LLP at [www.faruqilaw.com]. There is no cost or obligation to speak with the firm.

The deadline to file a motion to join the investigation is [insert deadline]. Investors who wish to join the investigation should contact the firm as soon as possible.

About Faruqi & Faruqi LLP Faruqi & Faruqi LLP is a nationally recognized law firm with a strong track record of success in securities cases. The firm has a dedicated team of securities attorneys who have a deep understanding of the securities laws and regulations that govern the markets. The firm's attorneys have a strong track record of success in recovering losses for investors who have been harmed by corporate wrongdoing.

Contact: Faruqi & Faruqi LLP Rebecca Ann Smith (212) 983-9331 rasmith@faruqilaw.com